Net Cash Provided by (Used in) Operating Activities |
-4.67K |
USD |
-12.4% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
4.67K |
USD |
+12.4% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
75M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
5.6M |
shares |
0% |
Sep 30, 2023 |
Q3 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
25K |
USD |
+14.8% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
21.8K |
USD |
+16.9% |
Dec 31, 2022 |
Q4 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
25K |
USD |
+14.8% |
Dec 31, 2023 |
Q4 2023 |
Additional Paid in Capital |
80.4K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Dec 31, 2022 |
Q4 2022 |